N-acetylcysteine + tigecycline + heparin

N-acetylcysteine + tigecycline + heparin is a combination drug formulation used primarily as a catheter-lock solution for the treatment and prevention of catheter-associated bacteremia, particularly in patients with hemodialysis catheters. This combination leverages the synergistic effects of its components: - **N-acetylcysteine (NAC)** acts as a mucolytic and antioxidant agent that disrupts biofilm formation by breaking down extracellular polysaccharide matrices, thereby enhancing the penetration and efficacy of antibiotics against biofilm-embedded bacteria. - **Tigecycline** is a broad-spectrum glycylcycline antibiotic effective against multidrug-resistant organisms, including methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis. It exhibits potent activity against both planktonic and biofilm-associated bacteria. - **Heparin** serves as an anticoagulant to maintain catheter patency during lock therapy. The combination has demonstrated synergistic antimicrobial activity in vitro and positive clinical outcomes in pilot trials for catheter salvage, with high rates of successful infection control without compromising anticoagulant function[1][2][4][5].

Other names

NAC/Tigecycline/Heparin combination lock solutionNAC-Tigecycline-Heparin lock solution